本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Atara Biotherapeutics

8.58
+0.11501.36%
盘后8.800.2182+2.54%17:37 EDT
成交量:3.38万
成交额:28.77万
市值:5,830.62万
市盈率:-0.75
高:8.68
开:8.30
低:8.21
收:8.47
数据加载中...
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/09

重要事件披露

Form 8-K - Current report
2024/01/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

SEC问询函

Form CORRESP - Correspondence
2023/11/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/11/01

重要事件披露

Form 8-K - Current report